-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Novel Autologous Approaches to CAR T

Program: Scientific Workshops @ ASH
Session: CAR-T and Other Cellular Therapy for Mutiple Myeloma
Thursday, December 3, 2020, 9:12 AM-9:57 AM

Marcela V. Maus, MD, PhD

Massachusetts General Hospital, Boston, MA

Disclosures: Maus: kite: Consultancy, Research Funding; century therapeutics: Current equity holder in private company; tcr2: Consultancy, Current equity holder in publicly-traded company; Novartis: Consultancy, Research Funding; arcellx: Consultancy, Research Funding.